Contact Information Trinity Healthcare Supply LLC 3206 NE 2nd Ave, Suite 3013 Miami, FL 33137 United States Email: [email protected] Phone: (844) 357-3601 SOURCE: altRx Source: altRx
Injectable tirzepatide (Zepbound) is FDA-approved, supported by large-scale trial data, and delivers the medication predictably through subcutaneous tissue
Just as important, we have seen no major complications in patients following DMR
What you might notice: Mild appetite reduction, particularly in the 24 to 72 hours after injection Slight nausea, especially after eating large or fatty meals A subtle sense of fullness that arrives sooner than expected Some people notice absolutely nothing at this stage Weight change in week one is typically minimal, zero to two pounds
Read on for all the important details
US 1 review Apr 24, 2025 I had a great experience with Joey Med